Immunohistochemistry, as a diagnostic tool, is covered by health insurance if performed on an inpatient basis; this also applies to the New Rural Cooperative Medical Care (NRCMC). However, the exact rate of reimbursement will vary depending on the health insurance policy of the patient's region.
Costs for immunohistochemistry:
1. Reagents: Immunohistochemistry testing requires the use of specific antibodies and chromogenic reagents;
2. Equipment: The use of microscopes and other laboratory equipment to analyze the samples;
3. Technical services: Involves the costs of operating and analyzing the samples by the pathologist and technician;
4, Management costs: including costs related to sample preservation, data management, and so on.
In summary, the feasibility of immunohistochemistry reimbursement depends on the specific health insurance policy of the patient's region, in which immunohistochemistry testing costs for inpatient patients are usually included in the reimbursement scope, while outpatient patients do not enjoy this treatment; reimbursement rate varies from place to place and needs to be in line with the conditions of the national health insurance, so the patient should be aware of the detailed rules of the local health insurance before applying for reimbursement to ensure that the costs are reasonably reimbursed. The company's website is a good source of information about the company's products and services, and the company's website.
Legal basis:
The Law of the People's Republic of China on Social Insurance
Article 28
Medical expenses that are in accordance with the basic medical insurance catalog of medicines, diagnostic and therapeutic items, standards of medical service facilities, as well as those for emergency treatment and salvation, shall be paid out of the basic medical insurance fund in accordance with state regulations.
Article 29
The portion of the medical expenses of the insured that should be paid by the basic medical insurance fund shall be settled directly between the social insurance administration organization and the medical institutions and drug business units. The administrative departments of social insurance and the administrative departments of health shall establish a settlement system for medical expenses incurred for medical treatment in other places, so as to facilitate the enjoyment of basic medical insurance by insured persons.